Mohamed, M. F. H., ElShafei, M. N., Ahmed, M. B., Abdalla, L. O., Ahmed, I., Elzouki, A., & Danjuma, M. i. (2021). The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost.

Mohamed, Mouhand F. H., Mohamad Nabil ElShafei, Mohamed Badie Ahmed, Lina O. Abdalla, Israa Ahmed, Abdel-Naser Elzouki, and Mohammed ibn-mas’ud Danjuma. "The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis." Clin Appl Thromb Hemost 2021.

Mohamed, Mouhand F. H., et al. "The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis." Clin Appl Thromb Hemost 2021.